Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders - Wikidata - awgldk - TriplyDB

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

http://www.wikidata.org/entity/Q24623179

about

Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy A user's guide to cannabinoid therapies in oncology Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy Potential effects of cannabidiol as a wake-promoting agent.The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Cannabis as a substitute for prescription drugs - a cross-sectional study Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.Cannabidiol as a Potential Treatment for Anxiety Disorders.The Pharmacological Basis of Cannabis Therapy for Epilepsy.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.Cannabinoids: new promising agents in the treatment of neurological diseases.A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy.Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid Evidences for the Anti-panic Actions of Cannabidiol.Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.Is there a role for cannabidiol in psychiatry?Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.Endocannabinoids in nervous system health and disease: the big picture in a nutshell.Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report.Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Cannabidiol reduces ethanol consumption, motivation and relapse in mice.

P2860

Q26767489-7A27EA71-1032-4B37-BEB1-C454E9943CE9 Q26786474-F649E1DA-FE48-4C37-ADC2-4B1B64F91A3F Q28075341-042886C4-6853-43AD-973B-D3358A20940B Q28818800-932D9BC0-EB40-4597-A9E2-FEDF28C7C41C Q30376980-1F9C4799-F2C7-472E-A3F2-CE854153144A Q30403787-D0FA168D-BAC6-48BF-BD2F-692CB1948E4A Q30442731-22B86400-7EA7-453A-9FA6-6E63AF10BD2B Q30842130-49037752-FAEF-45C1-B159-C28722426826 Q33621686-4F6D6DC4-4BC8-41C0-B0E3-3FCF6F8E9B2A Q33623423-548B1AE2-C636-4917-8745-4FE36FB7FF38 Q33650518-E5DEFF65-F8ED-45E4-84CC-D496D77CE7B7 Q33739885-046BE909-7F26-4131-A471-A2529362D898 Q33819365-33302F4B-3D1A-4532-AA01-A093E39027FF Q33877423-CAF6BA18-6B34-4B42-8EE2-C1DB90B0B880 Q34186015-F7CE1A16-CB9B-411F-AAC1-8687644ABAE9 Q34336645-C07B67B8-A952-4F73-835D-E4810548D4C7 Q34492624-592DA303-86EC-48D1-8F9C-ADCDFC3C3086 Q34509920-AE3F821E-37D3-4AE7-A956-AFC5E8AB8D28 Q34557613-46B83098-7963-4974-A9EA-A8866CCE9845 Q34676610-BAD82DF7-E9ED-48E9-AC3D-7E523848800E Q35431667-AF8A3459-811E-4350-81E4-B038814CB80F Q37306421-984AF2D0-505E-432C-8687-F2D30A5C8375 Q37401982-0C82E191-62CF-4995-A512-9E12AB499999 Q38102053-9348E948-8D4D-43FD-8028-4A4EC30C60DF Q38269376-14F31014-9095-4F38-B85D-04BA6FB3BF80 Q38598513-FDC46703-AE9F-41CB-89F6-73A5B5273F8A Q38634379-AE46FDA7-AD32-49E5-9667-1531F9FD27A5 Q38828985-0F52610C-DD64-4BEA-985A-51B5317C36C2 Q38848638-6F3C90FC-D3EE-45C0-9639-84F78989D6FF Q39098495-4BBFD9EB-AF7E-4BE1-8735-5D7910D4E6F4 Q39154540-3635087D-1CF5-4F1C-B09A-3B7EB6BE2342 Q39166556-6A272212-19D2-43D3-9616-83824E2429F1 Q40054798-4C4A0E5F-4321-454A-854A-240EEEFC68DF Q42112685-008598B1-4C75-460E-97DD-662333F3EF2B Q42163235-5122839D-885D-4B99-8F7F-EB17F83CB648 Q42320778-01515ED5-9CBA-48D8-B0CF-CD03005C5A74 Q42416589-D56F2C44-6574-409A-8562-1D6235009957 Q43196956-8A0097A4-3B85-4E18-9AFD-B9CCA53F8067 Q46293996-07C7962E-EF92-4E84-BA95-156833E2F369 Q47364438-0EE91C23-107C-4FCD-B2B2-12A15DB6E9BF

P2860

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

http://www.wikidata.org/entity/Q24623179

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@ast

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@en

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@nl

type

label

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@ast

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@en

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@nl

prefLabel

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@ast

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@en

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@nl

P1433

Q24623179-0AAA0714-D188-440E-9566-DAB20BDC78BE

P1476

Q24623179-D6D11013-3368-4743-8245-FE6B80DE5901

P2093

Q24623179-4294AEF1-A792-4979-9550-FF80EFC2A45F

Q24623179-6FF2A542-8B0E-429D-A28A-93E13FF23327

Q24623179-8A5F458D-80D9-45AD-B2D2-E3D298A7F67A

P2860

Q24623179-022ADB1E-4162-4F43-A7B6-FB734BCCA235

Q24623179-0696B5C7-1E59-4C6F-8DEC-592BC903C38C

Q24623179-07981B56-5B21-4DB5-89AE-3AD6468FE2E0

Q24623179-0A0D573C-62DC-498C-AE75-1F029A291FF5

Q24623179-0B7D4B8A-BD05-4C45-A1E5-9BB5BD405AE8

Q24623179-0CEA9723-6AA5-453E-81AD-C02BFE314DC0

Q24623179-0D53D525-B992-4AC7-A427-35C7A52A7FF9

Q24623179-0E1E74D7-F5F5-4112-A69C-E3231035BA83

Q24623179-0FB27C92-34BB-4D57-962E-8DDBFD3D4EB8

Q24623179-0FC51F13-FCAF-4F03-9D16-C6F683181642

P304

Q24623179-BD2E8E24-6061-4E34-B3DB-2A4657CBA6F5

P31

Q24623179-B2060455-2C19-48FC-ACDD-EB3F7BB09F80

P3181

Q24623179-44A24EBD-E0CC-4CD1-B812-E1A4D17342F1

P356

Q24623179-8DDFD126-5491-497D-BB31-D004E7922B25

P407

Q24623179-732B182C-2A21-4490-A927-8087FC4B04DF

P433

Q24623179-F8D994F1-0834-4FD8-B081-A53D899A9734

P478

Q24623179-8951BCBE-B716-48A1-BDFD-FC4EE0F02573

P50

Q24623179-0DD98946-7323-4BCC-B659-C21E1CD567FE

Q24623179-40CA57A7-E311-4F5B-A1DB-691FA7E62A68

Q24623179-7DEB018B-E9BA-4EEA-A28B-E3348B2D013A

P577

Q24623179-CE7A7F02-5D03-48D7-AC35-430BB709936B

P5875

Q24623179-7B811C1B-4E7B-4E66-B229-5049F7931ED2

P698

Q24623179-0B7508C0-B966-451D-83DA-721248BEA8D4

P921

Q24623179-4726D7CD-146A-4F95-BD09-A5CC6F8CCD48

Q24623179-E48E3CAA-7E94-4105-8284-1EEE24F0D598

P932

Q24623179-A4BD0227-C0A2-4414-8018-363FA5644F5D

P3181

P356

P1433

Philosophical Transactions of the Royal Society B

P1476

Multiple mechanisms involved i ...... idiol in psychiatric disorders

@en

P2093

Alline Cristina Campos

http://www.w3.org/2001/XMLSchema#string

Fabricio Araújo Moreira

http://www.w3.org/2001/XMLSchema#string

Francisco Silveira Guimarães

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L

5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

High-potency cannabis and the risk of psychosis

The orphan receptor GPR55 is a novel cannabinoid receptor

P304

3364-3378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3150996

http://www.w3.org/2001/XMLSchema#string

P356

10.1098/RSTB.2011.0389

http://www.w3.org/2001/XMLSchema#string

P407

P433

1607

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

Felipe V. Gomes

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232738386

http://www.w3.org/2001/XMLSchema#string

P698

23108553

http://www.w3.org/2001/XMLSchema#string

P921

P932

3481531

http://www.w3.org/2001/XMLSchema#string